Physician profile
Jeffrey Mono
NPI 1306869284
$1,226.81
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $874 · 2020: $331 · 2021: $21.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $302.41 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $175.66 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $136.59 | 2019-2020 | |
| Horizon Therapeutics Plc | $131.07 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $117.59 | 2019 | |
| Allergan, INC. | $98.29 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $69.60 | 2019 | |
| Alcon Vision LLC | $59.63 | 2019 | |
| Ocular Therapeutix, INC. | $44.11 | 2019-2020 | |
| Biotissue Holdings INC. | $23.87 | 2019 | |
| Shire North American Group INC | $21.63 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $20.40 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| The Cameron-Ehlen Group, INC. | $6.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Mono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.